Position:
Vice Chair of Pharmacy PracticePronouns:
she/herLocation:
HPB 137Phone:
(540) 665-4806Email: kjoyner2@xgcr.net
Employed Since:
2017Educational History:
Pharm.D. University of Missouri – Kansas City
Research:
1. Kolk K, Joyner KR, Belrhiti S, Johnson M, Morgan KMW. Potential impact of race and ethnicity on pharmacy residency match rate and match participation. Am J Pharm Educ. 2024;88(3):100649.
2. Reid NK, Joyner KR, Lewis-Wolfson TD. Baricitinib versus tocilizumab for the treatment of moderate to severe covid-19. Ann Pharmacother. 2023;57(7):769-775.
3. Switzer MP, Robinson JE, Joyner KR, Morgan KW. Atogepant for the prevention of episodic migraine in adults. SAGE Open Med. 2022;10:20503121221128688.
4. Morgan KW, Joyner KR. Eptinezumab: A calcitonin gene-related peptide monoclonal antibody infusion for migraine prevention. SAGE Open Med. 2021;9:20503121211050186.
5. Joyner KR, Morgan KW. Novel therapies in acute migraine management: small-molecule calcitonin gene-receptor antagonists and serotonin 1f receptor agonist. Ann Pharmacother. 2021;55(6):745-759.
6. Joyner KR, Walkerly A, Seidel K, et al. Comparison of narrow-versus broad-spectrum antibiotics in elderly patients with acute exacerbations of chronic obstructive pulmonary disease. J Pharm Pract. 2022;35(1):26-31.
7. Joyner KR, Soric MM, Boyle JA, et al. Mineralocorticoid receptor antagonist utilization in a nationally representative heart failure with reduced ejection fraction outpatient population: a cross-sectional study. Am J Ther. 2020;27(2):e165-e176.